|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Affymetrix (Santa Clara, California) (AFFX) Names GenoSplice as Its Preferred Data Analysis Service Provider Increasing Accessibility for Bioinformatics in Genomic Research
3/6/2013 10:10:52 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip® Human Transcriptome Array 2.0, the most comprehensive microarray available for alternative splicing detection. GenoSplice, a leader in genomic data analysis and alternative splicing, has developed a dedicated expression analysis solution, EASANA®, including analysis for Affymetrix’ microarrays, such as GeneChip® Exon 1.0 ST Array, GeneChip® Human Transcriptome Array 1.0, and the new GeneChip® Human Transcriptome Array 2.0. When combined with GenoSplice analysis services, these arrays provide the highest resolution profiling of the transcriptome available on a microarray at both the gene and exon level.
|
|
|
|
|
|
|
|
|
|
|